
Investing.com – Denmark stocks were higher after the close on Wednesday, as gains in the Consumer Goods, Healthcare and Software&Computer Services sectors led shares higher.
At the close in Copenhagen, the OMX Copenhagen 20 rose 2.32% to hit a new all time high.
The best performers of the session on the OMX Copenhagen 20 were Oersted AS (CSE:ORSTED), which rose 3.85% or 14.50 points to trade at 391.50 at the close. Meanwhile, Novo Nordisk A/S Class B (CSE:NOVOb) added 3.56% or 26.60 points to end at 774.80 and Coloplast A/S (CSE:COLOb) was up 2.81% or 21.80 points to 797.60 in late trade.
The worst performers of the session were Ambu A/S (CSE:AMBUb), which fell 2.63% or 3.10 points to trade at 114.90 at the close. Novozymes A/S B (CSE:NZYMb) declined 1.25% or 4.50 points to end at 354.30 and GN Store Nord (CSE:GN) was down 1.15% or 1.90 points to 163.60.
Falling stocks outnumbered advancing ones on the Copenhagen Stock Exchange by 81 to 63 and 15 ended unchanged.
Shares in Novo Nordisk A/S Class B (CSE:NOVOb) rose to all time highs; up 3.56% or 26.60 to 774.80.
Crude oil for March delivery was down 2.02% or 1.57 to $76.25 a barrel. Elsewhere in commodities trading, Brent oil for delivery in April fell 1.75% or 1.44 to hit $81.06 a barrel, while the April Gold Futures contract rose 0.89% or 18.20 to trade at $2,069.10 a troy ounce.
USD/DKK was unchanged 0.01% to 6.87, while EUR/DKK unchanged 0.01% to 7.45.
The US Dollar Index Futures was down 0.20% at 103.01.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.